URM1
gene geneOn this page
Also known as MGC2668
Summary
URM1 (ubiquitin related modifier 1, HGNC:28378) is a protein-coding gene on chromosome 9q34.11, encoding Ubiquitin-related modifier 1 (Q9BTM9). Acts as a sulfur carrier required for 2-thiolation of mcm(5)S(2)U at tRNA wobble positions of cytosolic tRNA(Lys), tRNA(Glu) and tRNA(Gln). It is a selective cancer dependency (DepMap: 80.2% of cell lines).
Enables sulfur carrier activity. Involved in tRNA thio-modification and tRNA wobble uridine modification. Predicted to be located in cytosol. Predicted to be active in nucleus.
Source: NCBI Gene 81605 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 33 total
- Cancer dependency (DepMap): dependent in 80.2% of screened cell lines
- MANE Select transcript:
NM_030914
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28378 |
| Approved symbol | URM1 |
| Name | ubiquitin related modifier 1 |
| Location | 9q34.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC2668 |
| Ensembl gene | ENSG00000167118 |
| Ensembl biotype | protein_coding |
| OMIM | 612693 |
| Entrez | 81605 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 6 protein_coding, 1 nonsense_mediated_decay
ENST00000372847, ENST00000372850, ENST00000372853, ENST00000470840, ENST00000483206, ENST00000899715, ENST00000928501
RefSeq mRNA: 3 — MANE Select: NM_030914
NM_001135947, NM_001265582, NM_030914
CCDS: CCDS48035, CCDS59148, CCDS6900
Canonical transcript exons
ENST00000372853 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001109945 | 128378036 | 128378106 |
| ENSE00001611809 | 128389666 | 128392016 |
| ENSE00001696807 | 128371374 | 128371415 |
| ENSE00003564216 | 128387816 | 128387897 |
| ENSE00003639110 | 128389261 | 128389309 |
Expression profiles
Bgee: expression breadth ubiquitous, 274 present calls, max score 96.62.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 61.8175 / max 329.5148, expressed in 1822 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 98755 | 61.8175 | 1822 |
Top tissues by expression
292 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| endometrium epithelium | UBERON:0004811 | 96.62 | gold quality |
| apex of heart | UBERON:0002098 | 95.00 | gold quality |
| parotid gland | UBERON:0001831 | 94.99 | silver quality |
| mucosa of transverse colon | UBERON:0004991 | 94.98 | gold quality |
| stromal cell of endometrium | CL:0002255 | 94.86 | gold quality |
| body of pancreas | UBERON:0001150 | 94.39 | gold quality |
| monocyte | CL:0000576 | 94.27 | gold quality |
| mononuclear cell | CL:0000842 | 94.14 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 94.13 | gold quality |
| leukocyte | CL:0000738 | 93.96 | gold quality |
| right adrenal gland | UBERON:0001233 | 93.54 | gold quality |
| body of stomach | UBERON:0001161 | 93.53 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 93.36 | gold quality |
| left adrenal gland | UBERON:0001234 | 93.33 | gold quality |
| heart left ventricle | UBERON:0002084 | 93.30 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 93.25 | gold quality |
| prefrontal cortex | UBERON:0000451 | 93.22 | gold quality |
| granulocyte | CL:0000094 | 93.11 | gold quality |
| cardiac ventricle | UBERON:0002082 | 93.06 | gold quality |
| right atrium auricular region | UBERON:0006631 | 92.98 | gold quality |
| transverse colon | UBERON:0001157 | 92.80 | gold quality |
| left coronary artery | UBERON:0001626 | 92.78 | gold quality |
| gastrocnemius | UBERON:0001388 | 92.75 | gold quality |
| right frontal lobe | UBERON:0002810 | 92.72 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 92.71 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 92.67 | gold quality |
| lower esophagus | UBERON:0013473 | 92.66 | gold quality |
| thoracic aorta | UBERON:0001515 | 92.57 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 92.56 | gold quality |
| skin of leg | UBERON:0001511 | 92.52 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 7.00 |
| E-MTAB-6524 | no | 71.14 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
109 targeting URM1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-9-5P | 100.00 | 72.28 | 2361 |
| HSA-MIR-4510 | 100.00 | 66.60 | 2050 |
| HSA-MIR-6127 | 100.00 | 66.76 | 2188 |
| HSA-MIR-6129 | 100.00 | 66.46 | 2080 |
| HSA-MIR-6130 | 100.00 | 66.69 | 2012 |
| HSA-MIR-6133 | 100.00 | 66.48 | 2064 |
| HSA-MIR-6870-5P | 99.99 | 68.55 | 2115 |
| HSA-MIR-1184 | 99.99 | 68.19 | 1458 |
| HSA-MIR-4534 | 99.99 | 66.58 | 1907 |
| HSA-MIR-23B-5P | 99.98 | 66.07 | 587 |
| HSA-MIR-4723-5P | 99.97 | 68.70 | 2034 |
| HSA-MIR-5698 | 99.97 | 68.49 | 2029 |
| HSA-MIR-7111-5P | 99.97 | 68.48 | 2062 |
| HSA-MIR-6825-5P | 99.96 | 69.81 | 3431 |
| HSA-MIR-185-3P | 99.95 | 67.01 | 1743 |
| HSA-MIR-5010-5P | 99.94 | 64.11 | 705 |
| HSA-MIR-627-3P | 99.90 | 71.42 | 3316 |
| HSA-MIR-4731-5P | 99.89 | 67.23 | 2537 |
| HSA-MIR-5682 | 99.89 | 72.56 | 1005 |
| HSA-MIR-7162-3P | 99.89 | 68.16 | 1682 |
| HSA-MIR-153-5P | 99.89 | 73.86 | 6317 |
| HSA-MIR-4447 | 99.85 | 67.81 | 2900 |
| HSA-MIR-4728-5P | 99.85 | 69.39 | 4718 |
| HSA-MIR-765 | 99.84 | 68.24 | 2442 |
| HSA-MIR-6756-5P | 99.82 | 67.97 | 2466 |
| HSA-MIR-6785-5P | 99.82 | 68.68 | 4428 |
| HSA-MIR-11181-3P | 99.75 | 66.38 | 2205 |
| HSA-MIR-92A-2-5P | 99.75 | 67.01 | 2164 |
| HSA-MIR-4306 | 99.72 | 70.50 | 3630 |
| HSA-MIR-6752-3P | 99.72 | 66.71 | 1587 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 80.2% of screened cell lines.
Literature-anchored findings (GeneRIF, showing 7)
- The UBA4-URM1 system represents the evolutionary link between protein conjugation and protein modification by sulfur carrier proteins. (PMID:18491921)
- Urm1 is activated by an unusual mechanism to yield a thiocarboxylate intermediate that serves as sulfur donor in tRNA thiolation reactions (PMID:19017811)
- Urm1 has a conserved dual role by integrating the functions of prokaryotic sulfur carriers with those of eukaryotic protein modifiers of the Ub family (PMID:21209336)
- observations suggest that Urm1 activation is more similar to that of a prokaryotic sulfur carrier protein than that of a ubiquitin-like protein (PMID:21245332)
- ubiquitin-like Urm1.Uba4 systems are conserved and exchangeable between human and yeast cells (PMID:25747390)
- Molecular basis for the bifunctional Uba4-Urm1 sulfur-relay system in tRNA thiolation and ubiquitin-like conjugation. (PMID:32901956)
- The emerging roles of ubiquitin-like protein Urm1 in eukaryotes. (PMID:33548388)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | urm1 | ENSDARG00000091198 |
| mus_musculus | Urm1 | ENSMUSG00000069020 |
| rattus_norvegicus | Urm1 | ENSRNOG00000026636 |
| drosophila_melanogaster | Urm1 | FBGN0053276 |
| caenorhabditis_elegans | WBGENE00185048 |
Protein
Protein identifiers
Ubiquitin-related modifier 1 — Q9BTM9 (reviewed: Q9BTM9)
All UniProt accessions (2): Q9BTM9, Q5T4A9
UniProt curated annotations — full annotation on UniProt →
Function. Acts as a sulfur carrier required for 2-thiolation of mcm(5)S(2)U at tRNA wobble positions of cytosolic tRNA(Lys), tRNA(Glu) and tRNA(Gln). Serves as sulfur donor in tRNA 2-thiolation reaction by being thiocarboxylated (-COSH) at its C-terminus by MOCS3. The sulfur is then transferred to tRNA to form 2-thiolation of mcm(5)S(2)U. Also acts as a ubiquitin-like protein (UBL) that is covalently conjugated via an isopeptide bond to lysine residues of target proteins such as MOCS3, ATPBD3, CTU2, USP15 and CAS. The thiocarboxylated form serves as substrate for conjugation and oxidative stress specifically induces the formation of UBL-protein conjugates.
Subunit / interactions. Component of a complex at least composed of URM1, CTU2/NCS2 and CTU1/ATPBD3.
Subcellular location. Cytoplasm. Cytosol. Nucleus.
Post-translational modifications. C-terminal thiocarboxylation occurs in 2 steps, it is first acyl-adenylated (-COAMP) via the hesA/moeB/thiF part of MOCS3, then thiocarboxylated (-COSH) via the rhodanese domain of MOCS3.
Pathway. tRNA modification; 5-methoxycarbonylmethyl-2-thiouridine-tRNA biosynthesis.
Similarity. Belongs to the URM1 family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9BTM9-1 | 1 | yes |
| Q9BTM9-2 | 2 | |
| Q9BTM9-3 | 3 |
RefSeq proteins (3): NP_001129419, NP_001252511, NP_112176* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR012675 | Beta-grasp_dom_sf | Homologous_superfamily |
| IPR015221 | Urm1 | Family |
| IPR016155 | Mopterin_synth/thiamin_S_b | Homologous_superfamily |
Pfam: PF09138
UniProt features (9 total): mutagenesis site 3, modified residue 2, splice variant 2, chain 1, cross-link 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BTM9-F1 | 94.60 | 0.93 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (3): 101, 101, 101
Mutagenesis-validated functional residues (3):
| Position | Phenotype |
|---|---|
| 101 | mildly decreases mocs3-dependent amp formation. |
| 101 | decreases mocs3-dependent amp formation. |
| 101 | abolishes mocs3-dependent amp formation and loss of nuclear localization. |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-6782315 | tRNA modification in the nucleus and cytosol |
MSigDB gene sets: 133 (showing top):
MORF_MBD4, CGGAARNGGCNG_UNKNOWN, GOBP_TRNA_METABOLIC_PROCESS, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP, MORF_PSMC2, PATIL_LIVER_CANCER, MORF_SKP1A, GOBP_RNA_MODIFICATION, GATA6_01, MORF_PPP6C, MORF_PPP2R4, GOBP_POST_TRANSLATIONAL_PROTEIN_MODIFICATION, GUO_HEX_TARGETS_UP, BENPORATH_NOS_TARGETS, TGTTTAC_MIR30A5P_MIR30C_MIR30D_MIR30B_MIR30E5P
GO Biological Process (4): tRNA wobble uridine modification (GO:0002098), protein urmylation (GO:0032447), tRNA thio-modification (GO:0034227), tRNA processing (GO:0008033)
GO Molecular Function (3): protein tag activity (GO:0031386), sulfur carrier activity (GO:0097163), protein binding (GO:0005515)
GO Cellular Component (3): nucleus (GO:0005634), cytosol (GO:0005829), cytoplasm (GO:0005737)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| tRNA processing | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| tRNA wobble base modification | 1 |
| protein modification by small protein conjugation | 1 |
| tRNA modification | 1 |
| RNA processing | 1 |
| tRNA metabolic process | 1 |
| molecular tag activity | 1 |
| molecular carrier activity | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| cytoplasm | 1 |
| intracellular anatomical structure | 1 |
Protein interactions and networks
STRING
810 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| URM1 | CTU1 | Q7Z7A3 | 996 |
| URM1 | MOCS3 | O95396 | 956 |
| URM1 | NFS1 | Q9Y697 | 821 |
| URM1 | MPST | P25325 | 816 |
| URM1 | UFM1 | P61960 | 802 |
| URM1 | CTU2 | Q2VPK5 | 757 |
| URM1 | GABARAPL2 | P60520 | 719 |
| URM1 | ELP3 | Q9H9T3 | 718 |
| URM1 | TRMT112 | Q9UI30 | 717 |
| URM1 | TST | Q16762 | 708 |
| URM1 | F5GZY7 | F5GZY7 | 708 |
| URM1 | FAU | P35544 | 706 |
| URM1 | MCM5 | P33992 | 691 |
| URM1 | KTI12 | Q96EK9 | 681 |
| URM1 | NEDD8 | Q15843 | 680 |
IntAct
26 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ACBD6 | NMT2 | psi-mi:“MI:0914”(association) | 0.870 |
| URM1 | CTU1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| URM1 | CTU1 | psi-mi:“MI:0407”(direct interaction) | 0.720 |
| THAP11 | HCFC1 | psi-mi:“MI:0914”(association) | 0.630 |
| URM1 | MOCS3 | psi-mi:“MI:0195”(covalent binding) | 0.590 |
| URM1 | MOCS3 | psi-mi:“MI:0915”(physical association) | 0.590 |
| URM1 | USP15 | psi-mi:“MI:0915”(physical association) | 0.500 |
| URM1 | CSE1L | psi-mi:“MI:0915”(physical association) | 0.500 |
| URM1 | CTU2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| URM1 | VIPR2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| CTU1 | HSPA1B | psi-mi:“MI:0914”(association) | 0.350 |
| URM1 | OGT | psi-mi:“MI:0914”(association) | 0.350 |
| URM1 | ELP1 | psi-mi:“MI:0914”(association) | 0.350 |
| STAC2 | EIF1AX | psi-mi:“MI:0914”(association) | 0.350 |
| CEP41 | ATP12A | psi-mi:“MI:0914”(association) | 0.350 |
| AJUBA | DHX16 | psi-mi:“MI:0914”(association) | 0.350 |
| AKAP7 | PRKAR2A | psi-mi:“MI:0914”(association) | 0.350 |
| ZDHHC21 | SPRYD4 | psi-mi:“MI:0914”(association) | 0.350 |
| URM1 | TOMM40 | psi-mi:“MI:0914”(association) | 0.350 |
| URM1 | flaN | psi-mi:“MI:0915”(physical association) | 0.000 |
| ASCC2 | URM1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| URM1 | TBL3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CDK11B | URM1 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (32): URM1 (Affinity Capture-RNA), URM1 (Affinity Capture-RNA), GDPGP1 (Co-fractionation), URM1 (Affinity Capture-RNA), URM1 (Two-hybrid), URM1 (Reconstituted Complex), URM1 (Affinity Capture-RNA), URM1 (Affinity Capture-MS), URM1 (Affinity Capture-MS), URM1 (Affinity Capture-MS), TOMM40 (Affinity Capture-MS), URM1 (Affinity Capture-MS), HIST2H3PS2 (Affinity Capture-MS), URM1 (Affinity Capture-MS), URM1 (Affinity Capture-MS)
ESM2 similar proteins: A0MDQ1, A5DTV4, A6R989, A6S5X1, A6ZVR0, A7ETU4, A7TQ77, A8IC48, A8P008, A9YUB5, B0D4J6, B0W3S2, B2WIC3, B3CKG1, B3H7G2, B3LTL7, B3M611, B3NFA2, B4GUT1, B4HVA2, B4J272, B4KYT0, B4LE67, B4MLV0, B4PCA1, B4QKW3, B5DQK2, B5FVI0, B6SXH2, G0SE11, P0CT26, P40554, Q0D6M1, Q148F0, Q16Y28, Q1E493, Q1HQ10, Q2U9H6, Q54QN0, Q59WK2
Diamond homologs: A0MDQ1, A3GFM6, A5DTV4, A6R989, A6S5X1, A6ZVR0, A7ETU4, A7TQ77, A8IC48, A8P008, A9YUB5, B0D4J6, B0W3S2, B2WIC3, B3CKG1, B3H7G2, B3LTL7, B3M611, B3NFA2, B4GUT1, B4HVA2, B4J272, B4KYT0, B4LE67, B4MLV0, B4PCA1, B4QKW3, B5DQK2, B5FVI0, B6SXH2, G0SE11, P0CT26, P40554, Q0D6M1, Q148F0, Q16Y28, Q1E493, Q1HQ10, Q2U9H6, Q54QN0
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
33 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 25 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
970 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 9:128378020:T:TA | acceptor_gain | 1.0000 |
| 9:128378103:CCCT:C | donor_gain | 1.0000 |
| 9:128378103:CCCTG:C | donor_loss | 1.0000 |
| 9:128378104:CCT:C | donor_gain | 1.0000 |
| 9:128378105:CTG:C | donor_loss | 1.0000 |
| 9:128378106:TG:T | donor_loss | 1.0000 |
| 9:128378107:G:C | donor_loss | 1.0000 |
| 9:128378107:G:GG | donor_gain | 1.0000 |
| 9:128378108:T:TC | donor_loss | 1.0000 |
| 9:128378109:G:GT | donor_loss | 1.0000 |
| 9:128378110:AGTAT:A | donor_loss | 1.0000 |
| 9:128387804:A:AG | acceptor_gain | 1.0000 |
| 9:128387805:T:G | acceptor_gain | 1.0000 |
| 9:128387810:TTCCA:T | acceptor_loss | 1.0000 |
| 9:128387811:TCCA:T | acceptor_loss | 1.0000 |
| 9:128387812:CCAG:C | acceptor_loss | 1.0000 |
| 9:128387813:CA:C | acceptor_loss | 1.0000 |
| 9:128387814:A:AG | acceptor_gain | 1.0000 |
| 9:128387814:A:AT | acceptor_loss | 1.0000 |
| 9:128387814:AG:A | acceptor_gain | 1.0000 |
| 9:128387814:AGG:A | acceptor_gain | 1.0000 |
| 9:128387814:AGGG:A | acceptor_gain | 1.0000 |
| 9:128387815:G:A | acceptor_gain | 1.0000 |
| 9:128387815:G:GT | acceptor_gain | 1.0000 |
| 9:128387815:GGG:G | acceptor_gain | 1.0000 |
| 9:128387815:GGGG:G | acceptor_gain | 1.0000 |
| 9:128387815:GGGGA:G | acceptor_gain | 1.0000 |
| 9:128387887:G:GT | donor_gain | 1.0000 |
| 9:128387894:GCGT:G | donor_gain | 1.0000 |
| 9:128387895:CGTG:C | donor_loss | 1.0000 |
AlphaMissense
648 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 9:128389281:T:C | L70P | 0.997 |
| 9:128389275:T:C | L68P | 0.995 |
| 9:128389298:T:A | W76R | 0.995 |
| 9:128389298:T:C | W76R | 0.995 |
| 9:128389709:T:C | F94S | 0.995 |
| 9:128389723:C:G | H99D | 0.995 |
| 9:128387831:T:C | L41P | 0.994 |
| 9:128389269:G:A | G66E | 0.994 |
| 9:128389287:A:T | N72I | 0.994 |
| 9:128389305:T:C | L78P | 0.994 |
| 9:128389723:C:A | H99N | 0.994 |
| 9:128389727:G:A | G100D | 0.994 |
| 9:128387879:T:C | F57S | 0.993 |
| 9:128389268:G:A | G66R | 0.993 |
| 9:128389268:G:C | G66R | 0.993 |
| 9:128389275:T:A | L68Q | 0.992 |
| 9:128389295:G:C | D75H | 0.992 |
| 9:128389725:C:A | H99Q | 0.992 |
| 9:128389725:C:G | H99Q | 0.992 |
| 9:128389703:T:A | V92D | 0.991 |
| 9:128389714:T:C | S96P | 0.991 |
| 9:128389721:T:C | L98P | 0.991 |
| 9:128389278:T:A | V69E | 0.990 |
| 9:128389297:C:A | D75E | 0.990 |
| 9:128389297:C:G | D75E | 0.990 |
| 9:128389726:G:C | G100R | 0.990 |
| 9:128389263:G:C | R64P | 0.989 |
| 9:128389721:T:A | L98Q | 0.989 |
| 9:128389269:G:T | G66V | 0.988 |
| 9:128389292:G:C | A74P | 0.988 |
dbSNP variants (sampled 300 via entrez): RS1000044256 (9:128387142 T>C), RS1000322117 (9:128385551 T>A,C,G), RS1000499153 (9:128372917 A>C,G,T), RS1000581783 (9:128370440 C>G,T), RS1000635785 (9:128370067 G>A), RS1000842238 (9:128376163 C>G), RS1000900145 (9:128382763 A>G), RS1001045466 (9:128379528 G>A,T), RS1001192432 (9:128391110 A>G), RS1001588782 (9:128371743 T>G), RS1001641142 (9:128371554 G>A,C), RS1001895090 (9:128371735 C>A,T), RS1002228401 (9:128378818 G>A), RS1002248499 (9:128377587 T>C), RS1002286144 (9:128373671 C>T)
Disease associations
OMIM: gene MIM:612693 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005951_65 | Body mass index | 5.000000e-09 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004340 | body mass index |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
16 total (human), top 16 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Smoke | decreases expression, increases abundance, increases expression | 2 |
| Cadmium Chloride | decreases expression, increases expression | 2 |
| sodium arsenite | decreases expression | 1 |
| perfluorooctanoic acid | decreases expression | 1 |
| perfluorooctane sulfonic acid | decreases expression | 1 |
| perfluoro-n-nonanoic acid | decreases expression | 1 |
| perfluorohexanesulfonic acid | decreases expression | 1 |
| ICG 001 | increases expression | 1 |
| 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid | increases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Atrazine | decreases expression | 1 |
| Ivermectin | decreases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Valproic Acid | increases expression | 1 |
| Vanadates | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.